Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Orphazyme A/S
  6. News
  7. Press Releases
    ORPHA   DK0060910917

ORPHAZYME A/S

(ORPHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ORPHAZYME A/S
09/06ORPHAZYME A/S : Final Deadline for Investors with Losses Exceeding $500K to Acti..
BU
09/03THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the ..
BU
08/31ORPHAZYME A/S : Interim Report First Half 2021 Investor Call.pdf
PU
08/31ORPHAZYME A/S : Interim Report First Half 2021 (Form 6-K)
PU
08/31ORPHAZYME A/S : Interim Report First Half 2021
PU
08/31ORPHAZYME A/S : reports business highlights and financial results in Interim Rep..
AQ
08/25Orphazyme to host Interim Report First Half 2021 investor call on August 31, ..
GL
08/24ORPHAZYME A/S : CytRx Highlights Orphazyme's Published Results From Its Phase 2/..
BU
08/23ORPHAZYME A/S : announces publication of results from its Phase 2/3 trial of ari..
AQ
08/05New publication date for Orphazyme's Interim Report H1 2021
GL
08/02ORPHAZYME A/S : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investo..
BU
07/21DEADLINE REMINDER : Law Offices of Howard G. Smith Reminds Investors of Looming ..
BU
07/20GLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class..
BU
07/19ORPH SHAREHOLDER ALERT : Bronstein, Gewirtz & Grossman, LLC Reminds Orphazyme A/..
BU
07/19CytRx Corporation Announces Closing of $10 Million Offering To Healthcare-Foc..
AQ
07/17EQUITY ALERT : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Orphazyme A/S Investor..
BU
07/17THE LAW OFFICES OF FRANK R. CRUZ : Announces the Filing of a Securities Class Ac..
BU
07/16GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces the..
BU
07/16INVESTOR ALERT : Law Offices of Howard G. Smith Announces the Filing of a Securi..
BU
07/16SHAREHOLDER ALERT : Robbins LLP Announces that Orphazyme A/S (ORPH) is Being Sue..
BU
07/15THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Orphazyme A/S (ORP..
BU
07/15GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Inv..
BU
07/15INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Orpha..
BU
07/13SHAREHOLDER ACTION ALERT : The Schall Law Firm Announces the Filing of a Class A..
BU
07/13EQUITY ALERT : ROSEN, A TOP RANKED LAW FIRM, Encourages Orphazyme A/S Investors ..
BU
07/12ORPHAZYME ALERT : Bragar Eagel & Squire, P.C. Announces that a Class Action Laws..
BU
07/12ORPHAZYME INVESTOR ALERT : Investors With Substantial Losses Have Opportunity to..
BU
06/28ORPHAZYME A/S : announces restructuring to focus resources on supporting a path ..
PU
06/28Orphazyme presents 36-month data supporting durable response to arimoclomol d..
GL
06/28Orphazyme announces restructuring to focus resources on supporting a path for..
GL
06/23Major shareholder announcement
GL
06/21CYTRX : Notes Orphazyme's Regulatory Update from the FDA on Arimoclomol for Niem..
AQ
06/18Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick..
GL
06/11ORPHAZYME A/S : Danish biotech firm joins meme stock ranks after share price sur..
AQ
06/11ORPHAZYME A/S : Company announcement dated June 11, 2021 (Form 6-K)
PU
06/11Orphazyme addresses recent trading activity
GL
05/14CytRx Comments on Quarterly Results and Year-toDate Progress
AQ
05/07Orphazyme announces topline data from pivotal trial of arimoclomol in Amyotro..
GL
04/28ORPHAZYME A/S : Company Presentation April 2021.pdf
PU
04/27Orphazyme to present at upcoming investor conferences
GL
04/22New long-term share-based incentive program
GL
04/01ORPHAZYME A/S : CytRx Notes Orphazyme's Announcement of Topline Results from Tri..
BU
03/29Orphazyme announces topline results from pivotal trial of arimoclomol for Inc..
GL
03/25Reporting of transactions in Orphazyme's shares made by persons discharging m..
GL
03/25Articles of Association for Orphazyme A/S
GL
03/25Capital increase of 3,854 shares in Orphazyme A/S as a result of the exercise..
GL
03/25Resolutions passed at the Annual General Meeting
GL
03/05CytRx Highlights Orphazyme's Appointment of New CEO Ahead of Potential Regula..
AQ
03/03CORRECTION : Notice to convene Annual General Meeting
AQ
03/03Notice to convene Annual General Meeting
GL
03/03ORPHAZYME A/S : Annual Report 2020 Presentation.pdf
PU
03/02ORPHAZYME A/S : Remuneration Report 2020
PU
03/02Orphazyme reports business highlights and financial results in Annual Report ..
GL
03/01Orphazyme appoints Christophe Bourdon as Chief Executive Officer
GL
02/26Orphazyme announces participation in upcoming virtual investor conferences
GL
02/25Capital increase of 80,553 shares (equivalent to approximately 0.23% of the e..
GL
02/23Orphazyme announces presentation of 2020 Annual Report
GL
02/15ORPHAZYME A/S : to showcase data on arimoclomol in Niemann-Pick disease Type C d..
PU
02/15ORPHAZYME A/S : Reporting of transactions in Orphazyme's shares made by persons ..
PU
02/15ORPHAZYME A/S : Capital increase of 170,131 shares in Orphazyme A/S as a result ..
PU
02/15ORPHAZYME A/S : Reporting of transaction in orphazyme's shares made by persons d..
PU
02/15ORPHAZYME A/S : Major shareholder announcement
PU
02/04Orphazyme to showcase data on arimoclomol in Niemann-Pick disease Type C duri..
GL
02/01Reporting of transactions in Orphazyme's shares made by persons discharging m..
GL
02/01Capital increase of 170,131 shares in Orphazyme A/S as a result of vesting an..
GL
01/18Major shareholder announcement
GL
01/04Orphazyme to take part in panel discussion at the LifeSci Partners 10th Annua..
GL
2020ORPHAZYME A/S : CytRx Issues Statement Regarding U.S. Regulatory Review of Arimo..
BU
2020Orphazyme provides regulatory update on arimoclomol for NPC
GL
2020ORPHAZYME A/S : - Bull story below Bear price
AQ
2020ORPHAZYME A/S : Kim Stratton, CEO, resigns from Orphazyme
AQ
2020Financial calendar 2021
GL
2020CYTRX : Announces Orphazyme's U.S. Expansion Ahead of Potential Regulatory Appro..
AQ
2020ORPHAZYME A/S : CytRx Announces Orphazyme's U.S. Expansion Ahead of Potential Re..
BU
2020Orphazyme establishes U.S. headquarters in Chicago as the company prepares fo..
GL
1  2  3Next
Upcoming event on ORPHAZYME A/S